See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2019_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 167,650,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 17,260,000 |
| 2 | PropertyPlantAndEquipmentNet | 187,000 |
| 3 | remainder_Assets | 369,000 |
| 4 | LiabilitiesCurrent | 12,825,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 50,004,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,741,810 |
| 9 | ResearchAndDevelopmentExpense | 36,352,914 |
| 10 | remainder_Expenses | -3,436,500 |
| 11 | remainder_Revenues | 35,710 |
| 12 | remainder_NetIncome | -4,816,742 |
| 13 | remainder_ComprehensiveNetIncome | -493,662 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 185,466,000 |
| 1 | Liabilities | 62,829,000 |
| 2 | Expenses | 50,658,224 |
| 3 | Revenues | 35,710 |
| 4 | StockholdersEquity | 122,637,000 |
| 5 | NetIncome | -55,439,256 |
| 6 | ComprehensiveNetIncome | -55,686,087 |
| 7 | BaseVar | 152,149,669 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.70 |
| 9 | EconomicCapitalRatio | 2.82 |